4.6 Review

Squamous Cell Carcinoma Antigen: Clinical Application and Research Status

期刊

DIAGNOSTICS
卷 12, 期 5, 页码 -

出版社

MDPI
DOI: 10.3390/diagnostics12051065

关键词

squamous cell carcinoma antigen; tumor marker; serine protease inhibitors; diagnosis; prognosis

向作者/读者索取更多资源

The squamous cell carcinoma antigen (SCCA) has potential clinical value as a tumor marker, but its diagnostic and prognostic accuracy is still controversial. Standardized detection methods and scoring systems need to be established, and dynamic observation is necessary.
The squamous cell carcinoma antigen (SCCA) is a tumor marker that has gained increasing attention for its biological functions and significance in normal physiological and pathological processes. Not only SCCA but also circulating immune complexes of SCCA and immunoglobulin M (IgM) are involved in normal physiological and pathological processes, providing a background for numerous clinical studies aimed at assessing the potential role of SCCA, SCCA-IgM, and SCCA isoform complexes in clinical practice. Previous studies support the clinical value of SCCA as a tumor marker for either diagnosing squamous cancers or monitoring the response to radiotherapy or chemotherapy, tumor relapse, and treatment failure. However, these studies show contrasting results, making the diagnostic or prognostic value of SCCA controversial. To reduce clinical heterogeneity across studies and achieve a more accurate and reliable comparison of results, a standardized detection method, scoring system, and cutoff level need to be established. Moreover, despite the fact that performances of different methods are comparable, the dynamic observation of tumor marker kinetics should be conducted under the same method.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据